{"id":"W2095031513","doi":"10.1007/s00280-012-1889-8","title":"A phase I study of bevacizumab, everolimus and panitumumab in advanced solid tumors","year":2012,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":44,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"National Cancer Institute; Institut national de la recherche scientifique; Amgen","keywords":"Everolimus; Bevacizumab; Panitumumab; Solid tumor; Medicine; Oncology; Internal medicine; Cancer research; Chemotherapy; Cancer; Colorectal cancer; KRAS","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001695018,0.0001818546,0.0002911652,0.00005966106,0.00004293551,0.000004532708,0.000108024,0.0001050564,0.0001352614],"category_scores_gemma":[0.000006542152,0.000180764,0.00002801418,0.00009498822,0.000145619,0.00001112455,0.0000515218,0.0001233628,4.259507e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003159275,"about_ca_system_score_gemma":0.00006261694,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000504591,"about_ca_topic_score_gemma":0.0000346159,"domain_scores_codex":[0.99896,0.00008679703,0.0002512665,0.000301701,0.0000739077,0.0003263821],"domain_scores_gemma":[0.9995753,0.00002100406,0.0001219329,0.0001324744,0.00004108857,0.0001082272],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001805643,0.001016036,0.01762492,0.0000539477,0.0001265197,0.000003040737,0.001675592,0.00004750119,0.952681,0.000003417039,0.0002645166,0.02469785],"study_design_scores_gemma":[0.02377674,0.002619117,0.00522897,0.00002004955,0.00006381537,0.00001770649,0.000491653,0.00008842928,0.9592952,0.00002823428,0.008066293,0.0003038686],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.988189,0.0108553,0.00002599393,0.00009758696,0.0003287683,0.000406772,0.00002045816,0.000008011562,0.00006813624],"genre_scores_gemma":[0.9965271,0.001994379,0.00005311313,0.0008584118,0.0003149871,0.0001615404,0.000006350684,0.00002705638,0.00005705108],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02439398,"threshold_uncertainty_score":0.7371341,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01769403803337643,"score_gpt":0.3676464043998438,"score_spread":0.3499523663664674,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}